Inovio Expands Enrollment in Ebola Vaccine Phase I Study

Late last week, Inovio Pharmaceuticals, Inc. INO announced that it is expanding the enrollment in a phase I study evaluating its Ebola DNA vaccine, … Full Article http://j.gs/5sTq

Click here to read full article